Amy McBride Wendell insider trades

Open-market stock purchases and sales by Amy McBride Wendell, Director at Axogen, Inc, from SEC Form 4 filings since Feb 4, 2010.

Track record: 100% of 4 scored buys are up 5% or more since purchase, averaging +76%.

Recent trades

DateStockTradeValue
Aug 11, 2026AXGN Axogen, IncSold$647K
Aug 11, 2026AXGN Axogen, IncBought (not open market)—
Jun 24, 2026AXGN Axogen, IncBought (not open market)—
Jun 19, 2026AXGN Axogen, IncBought (not open market)—
May 15, 2026SOLV Solventum CorpBought (not open market)—
May 8, 2026AXGN Axogen, IncSold$70.2K
May 8, 2026AXGN Axogen, IncBought (not open market)—
May 5, 2026BAX Baxter International IncBought (not open market)—
Apr 30, 2026SOLV Solventum CorpBought (not open market)—
Apr 7, 2026HOLX Hologic IncSold (not open market)—
Apr 7, 2026HOLX Hologic IncSold (not open market)$61.2K
Apr 7, 2026HOLX Hologic IncSold (not open market)$286K
Apr 7, 2026HOLX Hologic IncSold (not open market)$290K
Apr 7, 2026HOLX Hologic IncSold (not open market)$305K
Apr 7, 2026HOLX Hologic IncSold (not open market)$347K
Apr 7, 2026HOLX Hologic IncSold (not open market)$359K
Apr 7, 2026HOLX Hologic IncSold (not open market)$372K
Apr 7, 2026HOLX Hologic IncSold (not open market)$330K
Apr 7, 2026HOLX Hologic IncSold (not open market)$346K
Apr 7, 2026HOLX Hologic IncSold (not open market)$356K
Mar 27, 2026SOLV Solventum CorpBought (not open market)—
Mar 10, 2026SOLV Solventum CorpBought$100K
Feb 26, 2026HOLX Hologic IncBought (not open market)—
Dec 16, 2025AXGN Axogen, IncSold$147K
Dec 16, 2025AXGN Axogen, IncSold$599K

Companies traded

  • AXGN Axogen, Inc: 4 buys, 7 sales, last Aug 11, 2026
  • SOLV Solventum Corp: 1 buy, last May 15, 2026
  • BAX Baxter International Inc: other filings, last May 5, 2026
  • HOLX Hologic Inc: 1 buy, last Apr 7, 2026
  • EKSO Ekso Bionics Holdings, Inc: 1 buy, last Sep 14, 2017
  • COV Covidien plc: 11 sales, last Jan 26, 2015

Get free alerts when Amy McBride Wendell files a new trade →